Arrowstreet Capital
PAHC icon

Arrowstreet Capital’s Phibro Animal Health PAHC Stock Holding History

Arrowstreet Capital’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-86,782
Closed -$4.8M – 2079
2026
Q1 		$4.8M Sell
86,782
-114,947
-57% -$5.47M ﹤0.01% 1173
2025
Q4 		$7.54M Sell
201,729
-99,876
-33% -$4.06M ﹤0.01% 1020
2025
Q3 		$12.2M Buy
301,605
+26,539
+10% +$876K 0.01% 895
2025
Q2 		$7.03M Buy
275,066
+83,018
+43% +$1.81M 0.01% 1028
2025
Q1 		$4.1M Sell
192,048
-130,042
-40% -$2.91M ﹤0.01% 1082
2024
Q4 		$6.76M Buy
322,090
+84,599
+36% +$1.96M 0.01% 929
2024
Q3 		$5.35M Buy
237,491
+85,636
+56% +$1.65M ﹤0.01% 943
2024
Q2 		$2.55M Buy
151,855
+26,022
+21% +$418K ﹤0.01% 1017
2024
Q1 		$1.63M Buy
125,833
+61,129
+94% +$733K ﹤0.01% 1193
2023
Q4 		$749K Sell
64,704
-5,509
-8% -$62.2K ﹤0.01% 1154
2023
Q3 		$897K Sell
70,213
-12,603
-15% -$179K ﹤0.01% 1007
2023
Q2 		$1.14M Sell
82,816
-92,090
-53% -$1.32M ﹤0.01% 947
2023
Q1 		$2.68M Buy
174,906
+39,441
+29% +$603K ﹤0.01% 849
2022
Q4 		$1.82M Buy
135,465
+76,962
+132% +$1.03M ﹤0.01% 891
2022
Q3 		$778K Buy
+58,503
New +$1.01M ﹤0.01% 1031
2020
Q4 		– Sell
-55,453
Closed -$965K – 2470
2020
Q3 		$965K Buy
+55,453
New +$1.18M ﹤0.01% 1823
2014
Q4 		– Sell
-13,589
Closed -$305K – 1308
2014
Q3 		$305K Buy
+13,589
New +$272K ﹤0.01% 901

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Arrowstreet Capital's PAHC Position: Q2 2026 in Review

Arrowstreet Capital sold out of Phibro Animal Health (PAHC) in Q2 2026, closing a stake of 86,782 shares — an estimated $4.8M sold.

Arrowstreet Capital first reported a position in PAHC in Q3 2014 and held it in 17 quarters. The position peaked at $12.2M in Q3 2025. 209 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Arrowstreet Capital reported no remaining Phibro Animal Health position as of Q2 2026 after selling out during the quarter.
  • Arrowstreet Capital sold 86,782 Phibro Animal Health shares in Q2 2026, an estimated $4.8M.
  • Arrowstreet Capital first reported a position in Phibro Animal Health in Q3 2014 and held it in 17 quarters.
  • Arrowstreet Capital's Phibro Animal Health position peaked at $12.2M in Q3 2025.
  • 209 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Arrowstreet Capital's 13F filing for Q2 2026, filed 13 Aug 2026.